Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-26T19:29:12.324Z Has data issue: false hasContentIssue false

Deadly Sins of Antibiotic Abuse in China

Published online by Cambridge University Press:  11 April 2017

Zheng Wang
Affiliation:
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China Department of Clinical Medicine, Second Military Medical University, Shanghai, China.
Han Zhang
Affiliation:
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
Jun Han
Affiliation:
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
Hao Xing
Affiliation:
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
Meng-chao Wu
Affiliation:
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
Tian Yang*
Affiliation:
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
*
Address correspondence to Dr Tian Yang, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China (yangtian6666@hotmail.com).
Rights & Permissions [Opens in a new window]

Abstract

Type
Letters to the Editor
Copyright
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved 

To the Editor—China ranks first among the world’s most frequent users of antibiotics.Reference Xiao 1 In the hospital setting, ~70% of inpatients and ~20% of outpatients in China are prescribed antibiotics by doctors, which are both twice WHO’s expectation for these rates.Reference Li, Xu and Wang 2 In many developed countries and in the United States, these rates are ~30% of inpatients and ~15% of outpatients. The overuse of antibiotics not only may adversely affect their therapeutic efficacy but also may substantially increase the cost of health care and lead to lethal toxic or allergic reactions. Approximately 14,738,000 incidents of moderate-to-severe adverse effects related to antibiotic abuse are reported annually in China, and between 2001 and 2005, ~150,000 patients died annually of antibiotic abuse or overuse.Reference Xiao, Hou and Wang 3 Moreover, off-label and blind use of antibiotics without pathogen culture and sensitivity test can lead to increased antimicrobial resistance.Reference Zhang, Eggleston, Rotimi and Zeckhauser 4 Furthermore, the case-fatality rate of drug-resistant infections reached 11.7% in hospitalized patients in China in 2011.Reference Yang and Liu 5 Based on the data provided in the Mohnarin report,Reference Li, Liu and Xue 6 between 2007 and 2008 the detection rates of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE) were 73.6% and 79.5%, respectively, in 20 hospitals in China. These rates are by far the highest in history.

The irrational clinical practice of antibiotic use in China is mainly characterized by high frequency and intensity, long duration, high dose, abuse without definite indications, and the combination of multiple antibiotics without the support of evidence. The “7 deadly sins” behind antibiotic abuse in China include (1) blind dependence on antibiotics on the part of the patient, (2) lack of awareness of proper use of antibiotics on the part of the doctor, (3) compulsory acquisition of interest on the part of the hospital, (4) enormous loopholes in the drug sale and purchase market, (5) lack of strict management systems, (6) ineffective administrative supervision,Reference Currie, Lin and Zhang 7 Reference Ma 9 and (7) longstanding hospital systems that compensate doctors according to their prescription practices. In addition, antibiotic abuse in animal husbandry is almost an open secret in China. Some scholars worry that the Chinese people will regret these lax antimicrobial policies and that China may even enter a “post-antibiotic era” in which antibiotics are not longer effective, which would undoubtedly constitute a humanitarian disaster.

Antibiotic abuse and other pressing public health challenges have attracted the attention of policy makers in the Chinese government. In May 8, 2012, the Chinese government officially issued an “unprecedentedly strict” (the network-based language prevailing in China) document concerning the management of clinical application of antibiotic agents. Mr. Xiaowei Ma, Deputy Minister of the Ministry of Health of China, said that the Ministry of Health would take further measures to curb antibiotic abuse (1) by including further intensifying the management of clinical application of antibiotic agents by setting up relevant policies, (2) by strictly implementing regulations about staged management of antibiotic agents and the prescription review system, (3) by progressively enhancing the construction of networks on clinical application of antibiotics and supervision of dynamic surveillance as well as early warning on antibiotic resistance, and (4) by immediately taking specific actions to rectify improper clinical application of antibiotic agents.Reference Wang 10

Beyond China, antibiotic abuse has become a serious social issue threatening public health all over the world. We need to raise public awareness about the harmful nature of antibiotic abuse. Media should emphasize the importance of the rational use of antibiotics, and measures should be taken to improve public knowledge of both risks and benefits of antimicrobial therapy. In addition, education of doctors should be improved to ensure that they comply with such guidelines as well as the widely accepted recommendations for proper clinical diagnosis and treatment. Returning public hospitals to the track of public service, mobilizing the enthusiasm of medical workers, and preventing them from abusing antibiotics for personal gains are key to achieving the rational use of antibiotics.

ACKNOWLEDGMENTS

Financial support: No financial support was provided relevant to this article.

Potential conflicts of interest: All authors report no conflicts of interest relevant to this article.

Footnotes

*

These two authors contributed equally to this work.

References

REFERENCES

1. Xiao, YH. Bacterial resistance: challenge and strategies. China Lic Pharm 2011;8:38 (in Chinese).Google Scholar
2. Li, YB, Xu, J, Wang, F, et al. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Affairs 2012;31:10751082.Google Scholar
3. Xiao, Y, Hou, F, Wang, J, et al. An investigation into socio-economic impact of adverse drug reactions of antibacterial agent irrational use. Chin Health Econ 2010;29:9496 (in Chinese).Google Scholar
4. Zhang, R, Eggleston, K, Rotimi, V, Zeckhauser, RJ. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2006;2:6.CrossRefGoogle ScholarPubMed
5. Yang, F, Liu, SM. Attention to antibiotic resistance: the nightmare from medicine industry to food industry. Legal Syst Soc 2011;279:5658 (in Chinese).Google Scholar
6. Li, Y, Liu, J, Xue, F, et al. Antimicrobial susceptibility surveillance in China: a Mohnarin program 2007–2008 report. Chin J Clin Pharmacol 2011;27:323334 (in Chinese).Google Scholar
7. Currie, J, Lin, W, Zhang, W. Patient knowledge and antibiotic abuse: evidence from an audit study in China. J Health Econ 2011;30:933949.CrossRefGoogle ScholarPubMed
8. Chen, M. Analysis on the condition of, reasons for and control on antibiotic abuse. Jiangsu Health Care Manage 2005;16:4950 (in Chinese).Google Scholar
9. Ma, Y. Rational use of antibiotics to inhibit the extension of bacterial resistance. China Pharm 2011;26:24012403 (in Chinese).Google Scholar
10. Wang, CJ. Combat antibiotic abuse with multiple measures. Chin J Health 2011;5:4041 (in Chinese).Google Scholar